Abstract:Background: Recently, multiple preclinical studies have reported the beneficial effect of berberine in the treatment of Alzheimer's disease (AD). Nevertheless, the neuroprotective effects and possible mechanisms of berberine against AD are not universally recognized. This study aimed to conduct a systematic review and meta-analysis by integrating relevant animal studies to assess the neuroprotective effects and potential mechanisms of berberine on AD. Methods: We systematically searched PubMed, Embase, Scopus and Web of Science databases that reported the effects of berberine on AD models up to 1 February 2023. The escape latency, times of crossing platform, time spent in the target quadrant and pro-oligomerized amyloid beta 42 (Aβ 1-42 ) were included as primary outcomes. The secondary outcomes were the Tau-ps 204, Tau-ps 404, β-site of APP cleaving enzyme (BACE1), amyloid precursor protein (APP), acetylcholine esterase (AChE), tumor necrosis factor ⍺ (TNF-α), interleukin 1β (IL-1β), IL-6, nitric oxide (NO), glial fibrillary acidic protein (GFAP), malonaldehyde (MDA), glutathione S-transferase (GST), glutathione (GSH), glutathione peroxidase (GPx), Beclin-1 and neuronal apoptosis cells. This meta-analysis was conducted using RevMan 5.4 and STATA 15.1. The SYRCLE's risk of bias tool was used to assess the methodological quality. Results: Twenty-two studies and 453 animals were included in the analysis. The overall results showed that berberine significantly shortened the escape latency ( p < 0.00001), increased times of crossing platform ( p < 0.00001) and time spent in the target quadrant ( p < 0.00001), decreased Aβ 1-42 deposition ( p < 0.00001), Tau-ps 202 ( p < 0.00001) and Tau-ps 404 ( p = 0.002), and improved BACE1, APP, AChE, Beclin-1, neuronal apoptosis cells, oxidative stress and inflammation levels. Conclusion: Berberine may be a promising drug for the treatment of AD based on preclinical evidence (especially when the dose was 5–260 mg/kg). The potential mechanisms for these protective effects may be closely related to anti-neuroinflammation, anti-oxidative stress, modulation of autophagy, inhibition of neuronal apoptosis and protection of cholinergic system. However, these results may be limited by the quality of existing research. Larger and methodologically more rigorous preclinical research are needed to provide more convincing evidence.

Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer's disease: a systematic review and meta-analysis

Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer's disease models: a systematic review and meta-analysis

Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies

Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease

Berberine attenuates Aβ-induced neuronal damage through regulating miR-188/NOS1 in Alzheimer’s disease

Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer’s Disease Via Regulation of Β-Amyloid Production and Endoplasmic Reticulum Stress

Network pharmacology reveals that Berberine may function against Alzheimer's disease via the AKT signaling pathway

Berberine Mitigates Cognitive Decline in an Alzheimer's Disease Mouse Model by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance

Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and Β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.

The Neuroprotective Effects of Berberine Against Amyloid Β-Protein-induced Apoptosis in Primary Cultured Hippocampal Neurons Via Mitochondria-Related Caspase Pathway

The efficacy and mechanism of berberine in improving aging-related cognitive dysfunction: A study based on network pharmacology

Effect of berberine on microglia activation in rats with Alzheimer's disease

Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer’s Disease Mouse Model

Therapeutic potential of berberine against neurodegenerative diseases

Berberine Ameliorates Β-Amyloid Pathology, Gliosis, and Cognitive Impairment in an Alzheimer's Disease Transgenic Mouse Model

Berberine: A Promising Treatment for Neurodegenerative Diseases

Berberine ameliorates rats model of combined Alzheimer’s disease and type 2 diabetes mellitus via the suppression of endoplasmic reticulum stress

Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase.

Effect of berberine on the expression of phosphorylation tau proteins in frontal cortex of rats with Alzheimer's disease induced by okadaic acid

Berberine Alleviates Amyloid Β-Induced Mitochondrial Dysfunction and Synaptic Loss

Effects of Berberine on Diabetes and Cognitive Impairment in an Animal Model: The Mechanisms of Action